Labeling bladder cancer cell lines with anti-BTN3 antibody (clone 20.1) confirmed the expression of BTN3 isoforms on bladder tumor cell lines treated or not (online supplemental figure 4A). This evidence concerns the gene BTNL9 and urinary bladder neoplasm.